Literature DB >> 7507630

Increased expression of CD25 and adhesion molecules on peripheral blood lymphocytes of patients with Wegener's granulomatosis (WG) and ANCA positive vasculitides.

J Gutfleisch1, E Baumert, G Wolff-Vorbeck, M Schlesier, H J Strutz, H H Peter.   

Abstract

Peripheral blood lymphocytes of 29 c-ANCA positive WG patients fulfilling the ACR classification criteria were examined for the expression of various leukocyte surface molecules by dual marker cytofluorometry (FACStar, Becton Dickinson). Activation markers such as CD25, HLA-DR, CD29 and adhesion molecules (ICAM-1 and LFA-3) were clearly elevated in this group in comparison to 40 healthy volunteers. Similar results were obtained for p-ANCA positives vasculitides (n = 13) and, unexpectedly, also for patients suffering from cholesteatoma, a chronic, bacterial infection of the middle ear (n = 21). The results are discussed in view of a pathogenic model for WG and vasculitic disorders.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7507630     DOI: 10.1007/978-1-4757-9182-2_69

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  4 in total

Review 1.  Combination therapy in autoimmune disease: vasculitis.

Authors:  D Carruthers; P Bacon
Journal:  Springer Semin Immunopathol       Date:  2001

Review 2.  Pathogenesis of ANCA-Associated Pulmonary Vasculitis.

Authors:  Marco A Alba; J Charles Jennette; Ronald J Falk
Journal:  Semin Respir Crit Care Med       Date:  2018-11-07       Impact factor: 3.119

3.  Activated CD4+ and CD8+ T-cell subsets in Wegener's granulomatosis.

Authors:  M Schlesier; T Kaspar; J Gutfleisch; G Wolff-Vorbeck; H H Peter
Journal:  Rheumatol Int       Date:  1995       Impact factor: 2.631

Review 4.  T-helper cells as new players in ANCA-associated vasculitides.

Authors:  Wayel H Abdulahad; Peter Lamprecht; Cees G M Kallenberg
Journal:  Arthritis Res Ther       Date:  2011-08-23       Impact factor: 5.156

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.